Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Positron Emission Tomography
31%
Fluorodeoxyglucose F 18
24%
Fluorodeoxyglucose
22%
Polyethylene Terephthalate
21%
Diseases
20%
Computer Assisted Tomography
20%
Prostate Cancer
18%
Fluorine-18
17%
Positron Emission Tomography - Magnetic Resonance Imaging
17%
Magnetic Resonance Imaging
15%
Prostate Specific Membrane Antigen
15%
Standardized Uptake Value
14%
Neoplasm
14%
Pelvis
14%
Fever of Unknown Origin
11%
Overall Survival
9%
Scintigraphy
9%
Infection
9%
Retrospective Study
9%
Biological Marker
8%
Gallium 68
8%
Progression Free Survival
7%
Laparoscopic Sleeve Gastrectomy
7%
Stomach Emptying
6%
Retrospective Cohort Study
6%
Liver Metastasis
6%
Infective Endocarditis
6%
Chemoradiotherapy
6%
Endocarditis
5%
Lymph Node
5%
Radiomics
5%
Diffusion MRI
5%
Hodgkin's Lymphoma
5%
Helicobacter Pylori
5%
Prospective Study
5%
Non Small Cell Lung Cancer
5%
Choline
5%
Hybrid Imaging
5%
Cervical Cancer
5%
Diagnostic Performance
5%
Arm
5%
Esophageal Cancer
5%
MALT Lymphoma
5%
Cancer
5%
Malignant Neoplasm
5%
Biopsy Technique
5%
Keyphrases
Positron Emission Tomography-computed Tomography (PET-CT)
86%
PET-MRI
25%
SUVmax
23%
Positron Emission Tomography
22%
FDG Uptake
20%
Standardized Uptake Value
16%
18F-FDG PET-CT
15%
Prostate-specific Antigen
15%
Magnetic Resonance
12%
Magnetic Resonance Imaging
10%
FDG PET-CT
10%
Fever of Unknown Origin
10%
Fluorodeoxyglucose
8%
Pelvis
8%
Diagnostic Performance
8%
Ga-67
8%
Progression-free Survival
7%
Prostate Cancer
7%
Overall Survival
7%
Fluorodeoxyglucose Positron Emission Tomography (FDG-PET)
7%
Whole-body
7%
Laparoscopic Sleeve Gastrectomy
7%
18F-fluorodeoxyglucose (18F-FDG)
7%
Attenuation Correction
7%
Same-day
6%
Gastric Emptying
6%
Spleen
6%
Liver Metastasis
6%
Infective Endocarditis
6%
18F-fluorodeoxyglucose Positron Emission Tomography (18F-FDG PET)
6%
Computed Tomography
6%
Metabolic Tumor Volume
6%
Prostate
5%
Gastric Emptying Scintigraphy
5%
Liver
5%
Lymphoma
5%
Apparent Diffusion Coefficient
5%
Diffusion-weighted Imaging
5%
Hodgkin Lymphoma
5%
Abdomen
5%
Area under the Curve
5%
Metabolic
5%
Imaging Modalities
5%
CT Radiomics
5%
Early Prediction
5%
Crohn's Disease
5%
Early Dynamics
5%
Cervical Cancer
5%
Image Features
5%
Marginal Zone Lymphoma
5%